바이오인

2015 Profile, Biopharmaceutical Research Industry

Biopharmaceutical Innovation: Benefiting Patients and the US Economy

Biopharmaceutical companies make the medicines that save and improve patients’ lives every day. Patients often rely on medicines to keep their symptoms at bay and allow them to continue to work and live healthy, productive lives. Others rely on medicines to cure their disease or to prevent life-threatening complications that might keep them out of the hospital. These are just a few examples of how preion medicines offer important benefits to patients. In 2014, the US Food and Drug Administration approved a record number of new medicines, promising continued advancement in the treatment of a diverse range of diseases.

The ability of patients to access the medicines they need is not only essential to improve their health, but also to improve the quality and value of health care while managing costs. This is true because medicines have the potential to bring savings to other health care spending by preventing costly complications and care. Importantly, while medicines provide such tremendous value, they consistently represent just 10% of overall health care spending in the United States. ...................(계속) 

[TABLE OF CONTENTS]

Introduction
▶ Biopharmaceutical Innovation: Benefiting Patients and the US Economy

CHAPTER 1
▶ Helping Patients Live Longer and Healthier Lives
▶ Transforming Patients' Lives
▶ The Nature of Medical Progress

CHAPTER 2
▶ Improving the Quality and Value of Health Care
▶ The Health Benefits of Better Use of Medicine
▶ The Economic Benefits of Better Use of Medicine
▶ Gaps in Appropriate Use of Medicines

CHAPTER 3
▶ Growing the US Economy
▶ Economic Impact of Clinical Trials
▶ Venture Capital Investments
▶ Responding to Societal Need

CHAPTER 4
▶ R&D: Ushering in a New Era of Innovative Medicines for Patients
▶ Overview of the R&D Process
▶ The Evolving R&D Process
▶ Adapting to Changes and Challenges

CHAPTER 5
▶ The Promise of the Pipeline
▶ Examining the Pipeline

CONCLUSION
▶ Looking Ahead
▶ Appendix
▶ PhRMA: Who We Are
▶ PhRMA Leadership
▶ PhRMA Member Companies: Full Members & Research Associate Members
▶ PhRMA Annual Membership Survey: Definition of Terms
▶ List of Tables: Detailed Results from the PhRMA Annual Membership Survey

☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.